Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Equities
  • General
  • Health Care
  • Markets
  • Media
  • News
  • Penny Stocks

Generic Drugmaker Endo’s Bankruptcy: Lenders Suggest $465M Payment To Settle Dispute With Federal Entities: Report

By Vandana Singh
November 22, 7:56 AM
Endo International's (OTC: ENDPQ) lenders have reportedly proposed a fresh deal to settle with U.S.

ENDPQ

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

Ozempic’s Surging Demand Has Novo Nordisk Restricting It in Europe, Plus An Older Generation Diabetes Drug: What’s Next?

By Vandana Singh
Today, 3:30 PM
Novo Nordisk A/S (NYSE: NVO) plans to limit starter kit supplies of Ozempic (semaglutide) in Europe and reduce the distribution of Victoza (liraglutide), aiming to bolster Ozempic's production, which has experienced a 

NVO

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Penny Stocks
  • Small Cap

Alzheimer’s Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others

By Vandana Singh
Today, 3:16 PM
Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this 

ACIU

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Downgrades
  • Equities
  • General
  • Health Care
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas

Goldman Sachs Downgrades Incyte Amid Concerns Over Jakafi Studies, Competitiveness

By Vandana Singh
Today, 3:05 PM
Goldman Sachs downgraded Incyte Corp (NASDAQ: INCY), citing continued uncertainty around Jakafi (Ruxolitinib) lifecycle management ahead of the mid-27/late-28 EU/US 

INCY

Read More
2 minute read
  • Biotech
  • Contracts
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Is Skin Disease-Focused Connect Biopharma Stock Lower Today?

By Vandana Singh
Today, 1:20 PM
Connect Biopharma Holdings Limited (NASDAQ: CNTB) released topline results from Stage 2 (maintenance period) of its China pivotal trial evaluating rademikibart's (formerly known as CBP-201) efficacy and safety in patients with moderate-to-

CNTB

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks

Why Is Liver Cancer Focused Can-Fite BioPharma Stock Trading Higher Today?

By Vandana Singh
Today, 12:04 PM
Can-Fite BioPharma Ltd (NYSE: CANF) announced that a patient who participated in the Phase 2 Liver Cancer Study and was treated with namodenoson had a complete response and overall survival of 

CANF

Read More
1 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Legal
  • Markets
  • Media
  • Movers
  • News

Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today?

By Vandana Singh
Today, 11:59 AM
Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is invalid, marking a victory for Pfizer Inc (NYSE: PFE) / 

BNTX

Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Markets
  • Movers
  • News

Medtronic’s Q2 Earnings Beat Street View On Strong Surgical, Diabetes Devices, Lifts Annual Forecasts

By Vandana Singh
Today, 10:24 AM
Medtronic Plc's (NYSE: MDT) reported Q2 FY24 sales of $7.984 billion, up 5.3% Y/Y as reported and 5% organic, slightly beating the 

MDT

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Small Cap

Why Is Cancer Focused MorphoSys Stock Trading Lower Today?

By Vandana Singh
Today, 9:28 AM
MorphoSys AG (NASDAQ: MOR) released topline results from the Phase 3 MANIFEST-2 study investigating pelabresib, an investigational BET inhibitor, in combination with the JAK inhibitor ruxolitinib compared with placebo plus ruxolitinib in JAK inhibitor-naïve 

MOR

Read More
1 minute read
  • Biotech
  • Contracts
  • Equities
  • General
  • Health Care
  • Markets
  • News
  • Penny Stocks

Silo Pharma Collaborates With Medspray Pharma For Intranasal Technology For Stress Disorder Candidate

By Vandana Singh
Today, 8:00 AM
Silo Pharma Inc (NASDAQ: SILO) announced a new exclusive license agreement with Medspray Pharma BV for its proprietary patented soft mist nasal spray technology, the delivery mechanism selected for Silo's intranasal therapeutic drug SPC-15.

SILO

Posts pagination

Previous 1 … 113 114 115 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service